FDA Inspection 1076442 — Janssen Biologics B.V.
The FDA completed an inspection of Janssen Biologics B.V. on Jun 15, 2018 in Leiden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 15, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leiden (Netherlands)